Literature DB >> 17520217

Clinical features of autoimmune pancreatitis.

Shigeyuki Kawa1, Hideaki Hamano.   

Abstract

Autoimmune pancreatitis is a unique form of chronic pancreatitis characterized by a high serum IgG4 concentration, and complications involving various extrapancreatic lesions. It should be emphasized that autoimmune pancreatitis is easily misdiagnosed as pancreatic cancer. This disease predominantly affects elderly men. The major symptom at onset is obstructive jaundice, while severe abdominal pain is rare. Blood tests have shown abnormal results, which could be attributed mainly to the obstructive jaundice. With regard to autoantibodies, the positive rate for the antinuclear antibody is 40%; however, disease-specific autoantibodies are rarely found. About half of the patients with autoimmune pancreatitis have shown exocrine and endocrine dysfunctions. IgG4 is a sensitive and specific marker for diagnosing autoimmune pancreatitis. In differentiating between pancreatic cancer and autoimmune pancreatitis, IgG4 shows a sensitivity of 90%, a specificity of 98%, and an accuracy of 95%. HLA DRB1*0405-DQB1*0401 alleles are significantly associated with autoimmune pancreatitis, and may present a specific peptide which triggers the autoimmune response. Various imaging findings have shown pancreatic swelling, irregular narrowing of the main pancreatic duct, and stenosis of the lower bile duct. Histology shows a significant presence of lymphocytes, plasma cell infiltration, and fibrosis with abundant IgG4-bearing plasma cell infiltration. After corticosteroid treatment, imaging findings and pancreatic functions usually improve significantly. It is probable that autoimmune pancreatitis is an essentially progressive condition resulting in pancreatic stone formation in a similar way to ordinary chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520217     DOI: 10.1007/s00535-007-2044-x

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  28 in total

1.  Sclerosing pancreato-cholangitis responsive to steroid therapy.

Authors:  G W Erkelens; F P Vleggaar; W Lesterhuis; H R van Buuren; S D van der Werf
Journal:  Lancet       Date:  1999-07-03       Impact factor: 79.321

Review 2.  Autoimmune related pancreatitis.

Authors:  K Okazaki; T Chiba
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

3.  Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan.

Authors:  Isao Nishimori; Akiko Tamakoshi; Shigeyuki Kawa; Shigeki Tanaka; Kazuo Takeuchi; Terumi Kamisawa; Hiromitsu Saisho; Kenji Hirano; Keiya Okamura; Nobuyuki Yanagawa; Makoto Otsuki
Journal:  Pancreas       Date:  2006-04       Impact factor: 3.327

Review 4.  Characteristic pancreatic duct appearance in autoimmune chronic pancreatitis: a case report and review of the Japanese literature.

Authors:  A Horiuchi; S Kawa; T Akamatsu; Y Aoki; K Mukawa; N Furuya; Y Ochi; K Kiyosawa
Journal:  Am J Gastroenterol       Date:  1998-02       Impact factor: 10.864

5.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

6.  Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas.

Authors:  K Kawaguchi; M Koike; K Tsuruta; A Okamoto; I Tabata; N Fujita
Journal:  Hum Pathol       Date:  1991-04       Impact factor: 3.466

Review 7.  Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis.

Authors:  K Yoshida; F Toki; T Takeuchi; S Watanabe; K Shiratori; N Hayashi
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

8.  High prevalence of hypothyroidism in patients with autoimmune pancreatitis.

Authors:  Kenichi Komatsu; Hideaki Hamano; Yasuhide Ochi; Mari Takayama; Takashi Muraki; Kaname Yoshizawa; Akihiro Sakurai; Masao Ota; Shigeyuki Kawa
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

9.  Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation.

Authors:  Mari Takayama; Hideaki Hamano; Yasuhide Ochi; Hisanobu Saegusa; Kenichi Komatsu; Takashi Muraki; Norikazu Arakura; Yasuharu Imai; Osamu Hasebe; Shigeyuki Kawa
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

10.  Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration.

Authors:  Akihiro Shinji; Kenji Sano; Hideaki Hamano; Hiroshi Unno; Mana Fukushima; Naoshi Nakamura; Taiji Akamatsu; Shigeyuki Kawa; Kendo Kiyosawa
Journal:  Gastrointest Endosc       Date:  2004-04       Impact factor: 9.427

View more
  19 in total

1.  Conference report: Korea-Japan symposium on autoimmune pancreatitis.

Authors:  Seung Woo Park; Jae Bock Chung; Makoto Otsuki; Myung-Hwan Kim; Jae Hoon Lim; Shigeyuki Kawa; Tetsuhide Ito; Isao Nishimori; Ji Kon Ryu; Kazuichi Okazaki; Kyutaek Lee; Terumi Kamisawa
Journal:  Gut Liver       Date:  2008-09-30       Impact factor: 4.519

Review 2.  Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis.

Authors:  Kazuichi Okazaki; Shigeyuki Kawa; Terumi Kamisawa; Toru Shimosegawa; Masao Tanaka
Journal:  J Gastroenterol       Date:  2010-03       Impact factor: 7.527

Review 3.  Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis.

Authors:  Shigeyuki Kawa; Kazuichi Okazaki; Terumi Kamisawa; Toru Shimosegawa; Masao Tanaka
Journal:  J Gastroenterol       Date:  2010-02-02       Impact factor: 7.527

4.  Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 I. Concept and diagnosis of autoimmune pancreatitis.

Authors:  Kazuichi Okazaki; Shigeyuki Kawa; Terumi Kamisawa; Tetsuhide Ito; Kazuo Inui; Hiroyuki Irie; Takayoshi Nishino; Kenji Notohara; Isao Nishimori; Shigeki Tanaka; Toshimasa Nishiyama; Koichi Suda; Keiko Shiratori; Masao Tanaka; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2014-03-18       Impact factor: 7.527

5.  Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.

Authors:  Hyun Woo Lee; Sung-Hoon Moon; Myung-Hwan Kim; Dong Hui Cho; Jae Hyuck Jun; Kwangwoo Nam; Tae Jun Song; Do Hyun Park; Sang Soo Lee; Dong-Wan Seo; Sung Koo Lee
Journal:  J Gastroenterol       Date:  2018-01-23       Impact factor: 7.527

6.  Autoimmune pancreatitis with atypical imaging findings that mimicked an endocrine tumor.

Authors:  Cindy Neuzillet; Céline Lepère; Mostafa El Hajjam; Laurent Palazzo; Monique Fabre; Hajer Turki; Pascal Hammel; Philippe Rougier; Emmanuel Mitry
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

7.  Review of diagnostic criteria for autoimmune pancreatitis; for establishment of international criteria.

Authors:  Isao Nishimori; Saburo Onishi; Makoto Otsuki
Journal:  Clin J Gastroenterol       Date:  2008-03-19

8.  Autoimmune pancreatitis and concurrent small lymphocytic lymphoma: not just a coincidence?

Authors:  Tad Kim; Stephen R Grobmyer; Lisa R Dixon; Robert W Allan; Steven N Hochwald
Journal:  J Gastrointest Surg       Date:  2008-05-28       Impact factor: 3.452

9.  Clinical analysis of 36 cases of autoimmune pancreatitis in China.

Authors:  Xingang Zhang; Xinpeng Zhang; Wei Li; Li Jiang; Xiaoli Zhang; Yun Guo; Xiaofei Wang
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

10.  Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long-term follow-up study of 73 Japanese patients.

Authors:  Masahiro Maruyama; Norikazu Arakura; Yayoi Ozaki; Takayuki Watanabe; Tetsuya Ito; Suguru Yoneda; Masafumi Maruyama; Takashi Muraki; Hideaki Hamano; Akihiro Matsumoto; Shigeyuki Kawa
Journal:  Int J Rheumatol       Date:  2013-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.